Sanofi: encouraging results of Beyfortus against respiratory syncytial virus in infants

Real time


Euronext Paris

11:39:20 02/05/2024

Varia. 5d.

Varia. Jan 1

91.51
EUR

-1.69%

+3.04%

+1.99%

Beyfortus reduced the risk of hospitalizations due to respiratory syncytial virus (RSV) by 82% in infants under six months of age, compared to infants who had not been immunized against RSV, according to interim results of a current study published in The Lancet. These results are part of the three-year Nirse-Gal study carried out in Galicia (Spain), as part of a collaboration with the General Directorate of Public Health of the Regional Administration of the Autonomous Community of Galicia (Xunta de Galicia) and Sanofi.

© AOF – 2024

Sanofi: encouraging results of Beyfortus against respiratory syncytial virus in infants

09:59

A.O.

Sanofi: new positive data for Beyfortus

08:05

CF

Sanofi presents new positive data on Beyfortus in infants

07:30

DJ

Sanofi: largest increase in the CAC 40 at the close of Tuesday April 30, 2024

30/04

A.O.

SANOFI: Jefferies reiterates its advice on the stock

04/29

CF

SANOFI: Deutsche Bank is for sale on the file

04/29

ZD

SANOFI: JP Morgan is neutral on the stock

04/29

ZD

ANALYST OPINION OF THE DAY: Hermès, Orange, Renault, TotalEnergies, Rémy Cointreau, Amundi, UBS…

04/29

Our Logo

Sanofi: will present its advances at the ATS in San Diego

04/26

CF

Analyst opinions of the day: Hermès, Sanofi, STMicroelectronics, BNP Paribas, Pluxee, Valeo, Nestlé…

04/26

Our Logo

SANOFI: DZ Bank still neutral on the matter

04/25

ZD

European stock markets close lower; BHP offers nearly $39 billion for Anglo American acquisition

04/25

TM

Paris slows down after several company results

04/25

A.W.

CAC40: manages to reduce its losses at the end of the session

04/25

CF

European markets in the red, shower of results

04/25

A.O.

Market update – Europe closes in decline, the trajectory of the US economy worries

04/25

D

Sanofi: largest increase in the CAC 40 at the close of Thursday April 25, 2024

04/25

A.O.

CAC40: reduces its losses a little, rates remain at their zenith

04/25

CF

European stocks traded in the United States in the form of American depositary receipts are up slightly on Thursday morning

04/25

TM

CAC40: showered by US growth and inflation, Nasdaq -2%

04/25

CF

SANOFI: Positive opinion from Jefferies

04/25

ZD

Overview of Dpa-AFX: COMPANIES from 04/25/2024 – 3:15 p.m.

04/25

DP

Transcript: Sanofi, Q1 2024 Earnings Call, Apr 25, 2024

04/25

SANOFI: Sanofi’s good health in the 1st quarter praised by the markets

04/25

Alphavalue

Sanofi: drop in results in the 1st quarter, increase in turnover

04/25

TM

Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.

Period Day Week

More graphics

Sanofi is the leading European pharmaceutical group. The turnover by product family is distributed as follows: – pharmaceutical products (70.6%): prescription drugs in the fields of specialty medicine (59.3% of turnover; intended for the treatment of multiple sclerosis, diseases neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; intended mainly for the treatment of diabetes and cardiovascular diseases); – human vaccines (17.4%): pediatric vaccines, vaccines against influenza, meningitis and poliomyelitis, booster vaccines and vaccines intended for travelers and endemic areas; – consumer health products (12%). At the end of 2023, the group has 54 production sites around the world. The geographical distribution of turnover is as follows: France (5.5%), Europe (18.6%), United States (43%), North America (1.6%) and others (31.3%) .

More information about the company

Sale
Consensus

Purchase

Average recommendation

BUY

Last Closing Course

93.08
EUR

Average course objective

108.1
EUR

Gap / Average Objective

+16.09%

Consensus

Varia. Jan 1

Capi.

+2.03% 124 billion
+33.25% 699 billion
+25.43% 571 billion
-3.55% 364 billion
+18.16% 326 billion
+4.36% 286 billion
+15.02% 236 billion
+5.01% 198 billion
-10.39% 194 billion
-3.69% 149 billion

Pharmacies – Others

Download from Apple Store

OUR EXPERTS AT YOUR LISTENANCE

Monday – Friday 9 a.m. – 12 p.m. / 2 p.m. – 6 p.m.

Zonebourse, live stock market
-

-

PREV Microplastics spotted in (all) human testicles, their consequences on fertility under study
NEXT Say goodbye to mosquitoes this summer with this grandmother’s tip